Cas 38165-13-8,N-<2-hydroxy-2-(3,4,5-trimethoxyphenyl)ethyl>-3,4,5-trimethoxybenzamide

38165-13-8

Post Buying Request

Basic information

Product Name: N-<2-hydroxy-2-(3,4,5-trimethoxyphenyl)ethyl>-3,4,5-trimethoxybenzamide
Synonyms: N-<2-hydroxy-2-(3,4,5-trimethoxyphenyl)ethyl>-3,4,5-trimethoxybenzamide
CAS NO:38165-13-8
Molecular Formula:
Molecular Weight: 421.447
EINECS: N/A
Product Categories: N/A

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: N-<2-hydroxy-2-(3,4,5-trimethoxyphenyl)ethyl>-3,4,5-trimethoxybenzamide(CAS DataBase Reference)
NIST Chemistry Reference: N-<2-hydroxy-2-(3,4,5-trimethoxyphenyl)ethyl>-3,4,5-trimethoxybenzamide(38165-13-8)
EPA Substance Registry System: N-<2-hydroxy-2-(3,4,5-trimethoxyphenyl)ethyl>-3,4,5-trimethoxybenzamide(38165-13-8)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 38165-13-8(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

38165-13-8 Suppliers

Recommended suppliers

38165-13-8 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 38165-13-8 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 3,8,1,6 and 5 respectively; the second part has 2 digits, 1 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 38165-13:
(7*3)+(6*8)+(5*1)+(4*6)+(3*5)+(2*1)+(1*3)=118
118 % 10 = 8
So 38165-13-8 is a valid CAS Registry Number.

38165-13-8Upstream product

4521-61-3 3,4,5-Trimethoxybenzoyl chloride

38165-13-8Downstream Products

38165-13-8Relevant academic research and scientific papers

Synthesis of a 2,5-diaryloxazoline as a potential platelet-activating factor antagonist

Peet,Burkhart,Broersma,Heminger

, p. 419 - 423 (1994)

2,5-Bis-(3,4,5-trimethoxyphenyl)-2-oxazoline (5, MDL 100,270) was designed as a potential platelet-activating factor (PAF) antagonist on the basis of computer modeling comparison studies with known PAF antagonists. An efficient, four-step synthesis of oxa

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 38165-13-8